These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 23849849)

  • 21. Association between the CYP2C9 polymorphism and the drug metabolism phenotype.
    Topić E; Stefanović M; Samardzija M
    Clin Chem Lab Med; 2004 Jan; 42(1):72-8. PubMed ID: 15061384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of multi-dose activated charcoal in phenytoin toxicity secondary to genetic polymorphism.
    Chan BS; Sellors K; Chiew AL; Buckley NA
    Clin Toxicol (Phila); 2015 Feb; 53(2):131-3. PubMed ID: 25597548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin D receptor start codon polymorphism ( FokI) is related to bone mineral density in healthy adolescent boys.
    Strandberg S; Nordström P; Lorentzon R; Lorentzon M
    J Bone Miner Metab; 2003; 21(2):109-13. PubMed ID: 12601576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Homocysteine and bone loss in epilepsy.
    Elliott JO; Jacobson MP; Haneef Z
    Seizure; 2007 Jan; 16(1):22-34. PubMed ID: 17110134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults.
    Olmos JM; Hernández JL; García-Velasco P; Martínez J; Llorca J; González-Macías J
    Osteoporos Int; 2016 Jan; 27(1):105-13. PubMed ID: 26134682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients.
    Tomida K; Hamano T; Mikami S; Fujii N; Okada N; Matsui I; Nagasawa Y; Moriyama T; Ito T; Imai E; Isaka Y; Rakugi H
    Bone; 2009 Apr; 44(4):678-83. PubMed ID: 19111635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Val432Leu polymorphism of the CYP1B1 gene is associated with differences in estrogen metabolism and bone density.
    Napoli N; Rini GB; Serber D; Giri T; Yarramaneni J; Bucchieri S; Camarda L; Di Fede G; Camarda MR; Jain S; Mumm S; Armamento-Villareal R
    Bone; 2009 Mar; 44(3):442-8. PubMed ID: 18977467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacogenetics: reality or fiction? Or are we there yet?
    Lopes-Cendes I; Guerreiro CA
    Arq Neuropsiquiatr; 2011 Apr; 69(2A):151-2. PubMed ID: 21537550
    [No Abstract]   [Full Text] [Related]  

  • 30. The cytochrome P-450 2C9/2C19 but not the ABCB1 genetic polymorphism may be associated with the liver cytochrome 3A4 induction by phenytoin.
    Chhun S; Verstuyft C; Rizzo-Padoin N; Simoneau G; Becquemont L; Bergmann JF; Mouly S
    J Clin Psychopharmacol; 2012 Jun; 32(3):429-31. PubMed ID: 22561479
    [No Abstract]   [Full Text] [Related]  

  • 31. Influence of CYP2C9 genetic polymorphism and undernourishment on plasma-free phenytoin concentrations in epileptic patients.
    Ramasamy K; Narayan SK; Shewade DG; Chandrasekaran A
    Ther Drug Monit; 2010 Dec; 32(6):762-6. PubMed ID: 21068649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of calcium and vitamin D insufficiencies on serum parathyroid hormone and bone mineral density: analysis of the fourth and fifth Korea National Health and Nutrition Examination Survey (KNHANES IV-3, 2009 and KNHANES V-1, 2010).
    Joo NS; Dawson-Hughes B; Kim YS; Oh K; Yeum KJ
    J Bone Miner Res; 2013 Apr; 28(4):764-70. PubMed ID: 23045165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.
    Ferlin A; Selice R; Di Mambro A; Ghezzi M; Di Nisio A; Caretta N; Foresta C
    Osteoporos Int; 2015 Aug; 26(8):2193-202. PubMed ID: 25963234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiepileptic treatment is associated with bone loss: difference in drug type and region of interest.
    Salimipour H; Kazerooni S; Seyedabadi M; Nabipour I; Nemati R; Iranpour D; Assadi M
    J Nucl Med Technol; 2013 Sep; 41(3):208-11. PubMed ID: 23886631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum concentrations of 25-hydroxyvitamin D and its association with bone mineral density and serum parathyroid hormone levels during winter in urban males from Guiyang, Southwest China.
    Zhang Q; Shi L; Peng N; Xu S; Zhang M; Zhang S; Li H; Zhuang H; Gong M; Wu D; Wang R
    Br J Nutr; 2016 Mar; 115(6):960-6. PubMed ID: 26843386
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiepileptic drug-induced bone loss in young male patients who have seizures.
    Andress DL; Ozuna J; Tirschwell D; Grande L; Johnson M; Jacobson AF; Spain W
    Arch Neurol; 2002 May; 59(5):781-6. PubMed ID: 12020260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenytoin toxicity due to genetic polymorphism.
    McCluggage LK; Voils SA; Bullock MR
    Neurocrit Care; 2009; 10(2):222-4. PubMed ID: 19030785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecularly defined lactose malabsorption, peak bone mass and bone turnover rate in young finnish men.
    Enattah N; Välimäki VV; Välimäki MJ; Löyttyniemi E; Sahi T; Järvelä I
    Calcif Tissue Int; 2004 Dec; 75(6):488-93. PubMed ID: 15365657
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N; Kabra M; Gulati S; Gupta YK; Pandey RM; Bhatia BD
    BMC Pediatr; 2016 May; 16():66. PubMed ID: 27179628
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association between vitamin D levels and bone mineral density in patients with multiple sclerosis.
    Triantafyllou N; Lambrinoudaki I; Thoda P; Andreadou E; Kararizou E; Alexandrou A; Limouris G; Antoniou A; Tsivgoulis G
    J Neurol Sci; 2012 Feb; 313(1-2):137-41. PubMed ID: 21992813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.